At least, that's what your broker might tell you. But that's ridiculous. Our readers averaged 161% per month with these stocks last year alone. To find out everything you need to know about these "outlaw" stocks, just go here.
Jeremy Siegel: The Author of The Future for Investors & a Proponent of Dividend-Paying Stocks
by Mark Skousen, Chairman, Investment U
Tuesday, September 26, 2006: Issue #585
Last week I drove down to the University of Pennsylvania to interview Wharton’s premier financial economistJeremy Siegel, who has written two best sellers, Stocks for the Long Run and The Future forInvestors.Professor Siegel is on the cutting edge of research on the financial markets, both here and abroad. His discoveries often run counter to the conventional wisdom.
Siegel’s long-run charts on stocks, bonds, T-bills and gold demonstrate that stocks far outperform all other financial assets.
His latest book, The Future for Investors, reveals a paradox – that “tried and true companies triumph over the bold and the new.” I urge you to get a copy and devour it. It will make you a lot of money, and save you a lot of grief.
Here’s part one of our interview…
Jeremy Siegel’s Diversification Into International Stocks
Skousen: In your earlier book, Stocks for the Long Run, you argued that a stock market index like the S&P 500 was the best buy-and-hold investment, over bonds, T-bills and gold. Have you changed your mind?
Siegel: I still like the idea of “buy-and-hold,” although I now believe you should include at least 40% of your portfolio in international stocks. In addition, I am now associated with a management company called Wisdom Tree that has just issued dividend-weighted [rather than cap-weighted] exchange-traded funds. I prefer stock indexes that are weighted by some fundamental metric of value rather than market capitalization. Cap-weighted indexes aren’t bad, but you can do better. And “value” investing is better than “growth” investing.
Skousen: How about trading the market?
Siegel: It’s very difficult to time the market. I prefer value investing in good dividend-paying companies and reinvesting dividends.
Skousen: The Future for Investors has a number of shocking discoveries. For example, you state, “The most innovative companies are rarely the best place for investors Avoid most technology stocks Rapid productivity growth may be good for consumers and the economy, but they can be devastating to both firms and investors.” You call this the “growth trap” in your book. How so?
It’s funny. People go to the race track, and look at the odds. But in the stock market, people look at a stock and say, “this is the best stock” and don’t look at the price.
Skousen: I read that you like the “low P/E” stocks. But they are slow movers, right?
Siegel: Right, they’re not exciting, but they’re often the best performers over the long run.
Why Dividends Are A Powerful Predictor
Skousen: How important are dividends?
Siegel: I found that the dividend yield is a very powerful predictor of stock performance, and reinvesting dividends are critically important. Now, of course, some stocks like Ford and GM cut their dividends, but
Skousen: What percentage of companies cut their dividend?
Siegel: It’s tiny.
Skousen: Do you like stocks that consistently raise their dividends, and rising dividend funds?
Siegel: Ever since the tax rate was cut to 15% for dividends, more companies are paying dividends and increasing their dividends. If you just bought the stocks in the S&P 500 with the highest dividends over the past 50 years, you would have made 300 basis points per year more than the index itself. That’s a huge difference.
Skousen: You speak highly of Philip Morris, or Altria. But at $82 a share, and yield down to 4%, P/E of 15, is it still a good deal?
Siegel: I highlight Philip Morris in my book, but right now, it’s pretty much fully priced. I also like the big pharmaceuticals like Pfizer and Merck that pay a high dividend. Companies with a franchise and brand name get back on track eventually.
Skousen: How about GM and Ford?
Siegel: They have a big problem, especially with pension liabilities. They were never in the corporate El Dorados in my book; they were far too cyclical.
Chairman’s Note: On Friday, I’ll have the second half of Professor Siegel’s interview, where he talks about the benefits of owning high-dividend paying stocks such as REITs and Canadian oil & gas trusts; why junk bonds are better than safe Treasuries; why commodity stocks are better than commodities themselves; and the most important lesson he’s learned about investing in his 30 years at Wharton.
Good trading, AEIOU,
Mark

Professor Siegel and I in front of one of the original trading desks at the New York Stock Exchange.
Today’s Investment U Cribsheet
- To get your copy of The Future for Investors, find it here on Amazon.
- Collect 96 Dividend Checks A Year… Finding the most profitable dividend-paying companies is no small challenge. There are 385 companies in the S&P 500 that pay their shareholders regularly. And the average yield is just 1.98%. The Oxford Club’s Perpetual Money Portfolio, on the other hand, contains eight diversified investments that pay you 96 dividend checks a year – with an average yield of 8.46%. The capital appreciation is solid, too. As of 9-25-06, the income-producing Perpetual Money Portfolio is averaging 34% a year. Learn more about The Oxford Club.
- Nucor (NYSE: NUE) & The Golden Dividend Ratio
- The Dividend Stock Recovery: Get Ready for a High-Yield Bonanza
- Stock Dividends: Eliminating the Reasons Your Investments Fail
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
![]() |
![]() |











Investment U RSS Feed